Related references
Note: Only part of the references are listed.Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility:: role of Toll-like receptor 9
Pascal Knuefermann et al.
CARDIOVASCULAR RESEARCH (2008)
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock:: a randomised trial
Djillali Annane et al.
LANCET (2007)
Innate immunity and inflammation - New frontiers in comparative cardiovascular pathology
Annika Linde et al.
CARDIOVASCULAR RESEARCH (2007)
Toll-like receptor stimulation in cardiornyoctes decreases contractility and initiates an NF-κB dependent inflammatory response
John H. Boyd et al.
CARDIOVASCULAR RESEARCH (2006)
TLR9 in health and disease
Joerg Vollmer
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2006)
Modifying toll-like receptor 9 signalling for therapeutic use
RN Bhattacharjee et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload
TZ Ha et al.
CARDIOVASCULAR RESEARCH (2005)
Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung
H Yamada et al.
CRITICAL CARE MEDICINE (2004)
Toll-like receptors in cardiovascular diseases
D de Kleijn et al.
CARDIOVASCULAR RESEARCH (2003)
Share Paper
